In this context it would be of interest to study the effects of galantamine treatment on indices of hepatic pathology in patients with MetS as suppression of ALT and AST levels and amelioration of hepatic steatosis by this drug have these demonstrated in animal studies (30, 69). Here, GPT is linked to metabolic syndrome.